| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alternative Models of Cardiac Rehabilitation Delivery Urgently Needed to Improve Access for Heart Failure Patients
|
Taylor, Rod S.
|
|
|
|
8 |
p. 608-609
|
artikel
|
| 2 |
Application of Diagnostic Algorithms for Heart Failure With Preserved Ejection Fraction to the Community
|
Selvaraj, Senthil
|
|
|
|
8 |
p. 640-653
|
artikel
|
| 3 |
Aspirin Does Not Increase Heart Failure Events in Heart Failure Patients
|
Teerlink, John R.
|
|
2017
|
|
8 |
p. 603-610
8 p.
|
artikel
|
| 4 |
Associations Between Short or Long Length of Stay and 30-Day Readmission and Mortality in Hospitalized Patients With Heart Failure
|
Sud, Maneesh
|
|
2017
|
|
8 |
p. 578-588
11 p.
|
artikel
|
| 5 |
Atrial Fibrillation in Heart Failure ∗
|
Lam, Carolyn S.P.
|
|
2017
|
|
8 |
p. 575-577
3 p.
|
artikel
|
| 6 |
Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction
|
Cikes, Maja
|
|
2018
|
|
8 |
p. 689-697
|
artikel
|
| 7 |
Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction
|
Sartipy, Ulrik
|
|
2017
|
|
8 |
p. 565-574
10 p.
|
artikel
|
| 8 |
Beta-Blockers in Acute Heart Failure
|
Jondeau, Guillaume
|
|
2015
|
|
8 |
p. 654-656
3 p.
|
artikel
|
| 9 |
Can Academic Cardiology Divisions Survive?
|
O’Connor, Christopher M.
|
|
2016
|
|
8 |
p. 687-688
2 p.
|
artikel
|
| 10 |
Cardiac Amyloidosis as a Potential Confounder in Heart Failure With Preserved Ejection Fraction Trials
|
Schelbert, Erik B.
|
|
2017
|
|
8 |
p. 617-
1 p.
|
artikel
|
| 11 |
Cardiopulmonary Exercise Testing in Heart Failure
|
Malhotra, Rajeev
|
|
2016
|
|
8 |
p. 607-616
10 p.
|
artikel
|
| 12 |
Catecholamine-Mediated Pathways in Takotsubo Syndrome
|
Dias, Andre
|
|
2018
|
|
8 |
p. 720-721
|
artikel
|
| 13 |
Chronic Heart Failure Care and Costs
|
Cainzos-Achirica, Miguel
|
|
2018
|
|
8 |
p. 723-724
|
artikel
|
| 14 |
Clinical Implications of Intrarenal Hemodynamic Evaluation by Doppler Ultrasonography in Heart Failure
|
Iida, Noriko
|
|
2016
|
|
8 |
p. 674-682
9 p.
|
artikel
|
| 15 |
Clinical Phenogrouping and Systolic Performance in HFpEF
|
Mehmood, Muddassir
|
|
|
|
8 |
p. 695
|
artikel
|
| 16 |
Combined Free Light Chains Are Novel Predictors of Prognosis in Heart Failure
|
Jackson, Colette E.
|
|
2015
|
|
8 |
p. 618-625
8 p.
|
artikel
|
| 17 |
Considerations for Heart Failure Care During the COVID-19 Pandemic
|
DeFilippis, Ersilia M.
|
|
|
|
8 |
p. 681-691
|
artikel
|
| 18 |
Correction
|
|
|
2017
|
|
8 |
p. 620-
1 p.
|
artikel
|
| 19 |
Correction
|
|
|
2019
|
|
8 |
p. 735-736
|
artikel
|
| 20 |
Correction
|
|
|
|
|
8 |
p. 700
|
artikel
|
| 21 |
Design Elements and Enrollment Patterns of Contemporary Trials in Heart Failure With Preserved Ejection Fraction
|
Samman Tahhan, Ayman
|
|
2018
|
|
8 |
p. 714-717
|
artikel
|
| 22 |
Diagnostic Algorithms for Heart Failure With Preserved Ejection Fraction ∗
|
Nagueh, Sherif F.
|
|
|
|
8 |
p. 654-656
|
artikel
|
| 23 |
Differential Pathophysiological Mechanisms in Heart Failure With a Reduced or Preserved Ejection Fraction in Diabetes
|
Packer, Milton
|
|
|
|
8 |
p. 535-549
|
artikel
|
| 24 |
Does Institutional Memory Matter?
|
O’Connor, Christopher M.
|
|
2017
|
|
8 |
p. 616-
1 p.
|
artikel
|
| 25 |
Duration of Diabetes and Incident Heart Failure
|
Echouffo-Tcheugui, Justin B.
|
|
|
|
8 |
p. 594-603
|
artikel
|
| 26 |
Effects of Beta-Blocker Withdrawal in Acute Decompensated Heart Failure
|
Prins, Kurt W.
|
|
2015
|
|
8 |
p. 647-653
7 p.
|
artikel
|
| 27 |
Effects of Dapagliflozin According to the Heart Failure Collaboratory Medical Therapy Score
|
Butt, Jawad H.
|
|
|
|
8 |
p. 543-555
|
artikel
|
| 28 |
Elevated Plasma B-Type Natriuretic Peptide Concentrations Directly Inhibit Circulating Neprilysin Activity in Heart Failure
|
Vodovar, Nicolas
|
|
2015
|
|
8 |
p. 629-636
8 p.
|
artikel
|
| 29 |
Empagliflozin-Induced Changes in Epicardial Fat
|
Mullens, Wilfried
|
|
|
|
8 |
p. 590-593
|
artikel
|
| 30 |
Empower the Future… Even Oprah Had a Mentor!
|
Psotka, Mitchell A.
|
|
|
|
8 |
p. 604-605
|
artikel
|
| 31 |
Epicardial Adipose Tissue and Invasive Hemodynamics in Heart Failure With Preserved Ejection Fraction
|
Gorter, Thomas M.
|
|
|
|
8 |
p. 667-676
|
artikel
|
| 32 |
Exercise-Based Rehabilitation for Heart Failure
|
Taylor, Rod S.
|
|
2019
|
|
8 |
p. 691-705
|
artikel
|
| 33 |
Exercise Rehabilitation for Heart Failure
|
Fleg, Jerome L.
|
|
2019
|
|
8 |
p. 706-708
|
artikel
|
| 34 |
Expenditure on Heart Failure in the United States
|
Bhatnagar, Roshni
|
|
|
|
8 |
p. 571-580
|
artikel
|
| 35 |
Expenditure on Heart Failure in the United States
|
Whellan, David J.
|
|
|
|
8 |
p. 581-582
|
artikel
|
| 36 |
Exploring the Mechanisms of Exercise Intolerance in Patients With HFpEF
|
Wolfel, Eugene E.
|
|
2016
|
|
8 |
p. 646-648
3 p.
|
artikel
|
| 37 |
Falling Cardiovascular Mortality in Heart Failure With Reduced Ejection Fraction and Implications for Clinical Trials
|
Rush, Christopher J.
|
|
2015
|
|
8 |
p. 603-614
12 p.
|
artikel
|
| 38 |
Fat, Female, Fatigued
|
Lam, Carolyn S.P.
|
|
2018
|
|
8 |
p. 710-713
|
artikel
|
| 39 |
Goal-Directed Heart Failure Care in Patients With Chronic Kidney Disease and End-Stage Renal Disease ∗
|
McCullough, Peter A.
|
|
2016
|
|
8 |
p. 662-663
2 p.
|
artikel
|
| 40 |
Heart Failure Collaboratory Statement on Remote Monitoring and Social Distancing in the Landscape of COVID-19
|
Abraham, William T.
|
|
|
|
8 |
p. 692-694
|
artikel
|
| 41 |
Heart Failure With Preserved Ejection Fraction Expert Panel Report
|
Parikh, Kishan S.
|
|
2018
|
|
8 |
p. 619-632
|
artikel
|
| 42 |
Hemodynamic and Functional Impact of Epicardial Adipose Tissue in Heart Failure With Preserved Ejection Fraction
|
Koepp, Katlyn E.
|
|
|
|
8 |
p. 657-666
|
artikel
|
| 43 |
Hemodynamic Correlates and Diagnostic Role of Cardiopulmonary Exercise Testing in Heart Failure With Preserved Ejection Fraction
|
Reddy, Yogesh N.V.
|
|
2018
|
|
8 |
p. 665-675
|
artikel
|
| 44 |
Hemodynamic Effects of Weight Loss in Obesity
|
Reddy, Yogesh N.V.
|
|
2019
|
|
8 |
p. 678-687
|
artikel
|
| 45 |
HFpEF
|
O’Connor, Christopher M.
|
|
2018
|
|
8 |
p. 718-719
|
artikel
|
| 46 |
HFpEF, Obesity, and Epicardial Adipose Tissue
|
Tedford, Ryan J.
|
|
|
|
8 |
p. 677-680
|
artikel
|
| 47 |
Holding the Readmission Gates
|
Fonarow, Gregg C.
|
|
2017
|
|
8 |
p. 589-590
2 p.
|
artikel
|
| 48 |
Human Immunodeficiency Virus and Heart Failure in Low- and Middle-Income Countries
|
Bloomfield, Gerald S.
|
|
2015
|
|
8 |
p. 579-590
12 p.
|
artikel
|
| 49 |
Impact of Diabetes on Outcomes After Transcatheter Mitral Valve Repair in Heart Failure
|
Shahim, Bahira
|
|
|
|
8 |
p. 559-567
|
artikel
|
| 50 |
Impact of Malnutrition Using Geriatric Nutritional Risk Index in Heart Failure With Preserved Ejection Fraction
|
Minamisawa, Masatoshi
|
|
2019
|
|
8 |
p. 664-675
|
artikel
|
| 51 |
Impact of Malnutrition Using Geriatric Nutritional Risk Index in Heart Failure With Preserved Ejection Fraction ∗
|
Clark, Andrew L.
|
|
2019
|
|
8 |
p. 676-677
|
artikel
|
| 52 |
Impaired Exercise Tolerance in Heart Failure With Preserved Ejection Fraction
|
Nayor, Matthew
|
|
|
|
8 |
p. 605-617
|
artikel
|
| 53 |
Inside This Issue
|
|
|
2015
|
|
8 |
p. A17-A20
nvt p.
|
artikel
|
| 54 |
Intrarenal Venous Flow
|
Tang, W.H. Wilson
|
|
2016
|
|
8 |
p. 683-686
4 p.
|
artikel
|
| 55 |
It Is Time to Screen for Heart Failure
|
Bozkurt, Biykem
|
|
|
|
8 |
p. 598-600
|
artikel
|
| 56 |
Left Atrial Pressure
|
Hasenfuss, Gerd
|
|
2018
|
|
8 |
p. 676-677
|
artikel
|
| 57 |
Light Chains and the Failing Heart
|
Januzzi Jr., James L.
|
|
2015
|
|
8 |
p. 626-628
3 p.
|
artikel
|
| 58 |
Mechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF
|
Requena-Ibáñez, Juan Antonio
|
|
|
|
8 |
p. 578-589
|
artikel
|
| 59 |
Mineralocorticoid Receptor Antagonism for the Treatment of AF and HFpEF
|
DeVore, Adam D.
|
|
2018
|
|
8 |
p. 698-700
|
artikel
|
| 60 |
Mineralocorticoid Receptor Antagonist Improves Cardiac Structure in Type 2 Diabetes
|
Brandt-Jacobsen, Niels H.
|
|
|
|
8 |
p. 550-558
|
artikel
|
| 61 |
Modifiable Risk Factors for Incident Heart Failure in Atrial Fibrillation
|
Chatterjee, Neal A.
|
|
2017
|
|
8 |
p. 552-560
9 p.
|
artikel
|
| 62 |
Myocardial Infarction in Heart Failure With Preserved Ejection Fraction
|
Cunningham, Jonathan W.
|
|
|
|
8 |
p. 618-626
|
artikel
|
| 63 |
Neprilysin
|
Seronde, Marie-France
|
|
2015
|
|
8 |
p. 645-646
2 p.
|
artikel
|
| 64 |
Neprilysin in Heart Failure
|
Bayés-Genís, Antoni
|
|
2015
|
|
8 |
p. 637-640
4 p.
|
artikel
|
| 65 |
Novel Biomarkers of Cardiac Stress, Cardiovascular Dysfunction, and Outcomes in HIV-Infected Individuals
|
Secemsky, Eric A.
|
|
2015
|
|
8 |
p. 591-599
9 p.
|
artikel
|
| 66 |
Obesity-Related Heart Failure With a Preserved Ejection Fraction
|
Packer, Milton
|
|
2018
|
|
8 |
p. 633-639
|
artikel
|
| 67 |
Of Probabilities and Uncertainties
|
Roger, Véronique L.
|
|
2018
|
|
8 |
p. 686-688
|
artikel
|
| 68 |
Omega-3 Fatty Acids and Heart Failure
|
Maggioni, Aldo P.
|
|
2019
|
|
8 |
p. 662-663
|
artikel
|
| 69 |
On the Way to Accurately Evaluate Cardiac Function in Patients With Heart Failure
|
Huang, Gang
|
|
2019
|
|
8 |
p. 733-734
|
artikel
|
| 70 |
Out of Nowhere
|
Tatum, Reiss
|
|
2017
|
|
8 |
p. 615-
1 p.
|
artikel
|
| 71 |
Over the Edge
|
Feher, Attila
|
|
|
|
8 |
p. 595-597
|
artikel
|
| 72 |
Patient Phenotypes and SGLT-2 Inhibition in Type 2 Diabetes
|
Sharma, Abhinav
|
|
|
|
8 |
p. 568-577
|
artikel
|
| 73 |
Perhexiline, Cardiac Energetics, and Heart Failure
|
Davogustto, Giovanni
|
|
2015
|
|
8 |
p. 659-660
2 p.
|
artikel
|
| 74 |
Personalized Medicine
|
Raparelli, Valeria
|
|
2019
|
|
8 |
p. 732-733
|
artikel
|
| 75 |
Plasma Corin as a Predictor of Cardiovascular Events in Patients With Chronic Heart Failure
|
Zhou, Xiang
|
|
2016
|
|
8 |
p. 664-669
6 p.
|
artikel
|
| 76 |
Pragmatic Clinical Trials
|
Mehmood, Muddassir
|
|
|
|
8 |
p. 606
|
artikel
|
| 77 |
Predicting Risk for Incident Heart Failure With Omega-3 Fatty Acids
|
Block, Robert C.
|
|
2019
|
|
8 |
p. 651-661
|
artikel
|
| 78 |
Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Cardiomyopathy ∗
|
Daubert, James P.
|
|
2019
|
|
8 |
p. 725-727
|
artikel
|
| 79 |
Prognostic Implications of Staging Right Heart Failure in Patients With Significant Secondary Tricuspid Regurgitation
|
Dietz, Marlieke F.
|
|
|
|
8 |
p. 627-636
|
artikel
|
| 80 |
Prognostic Value and Kinetics of Soluble Neprilysin in Acute Heart Failure
|
Bayés-Genís, Antoni
|
|
2015
|
|
8 |
p. 641-644
4 p.
|
artikel
|
| 81 |
Putting Together the Pieces of the Natriuretic Peptide Puzzle ∗
|
Gommans, D.H. Frank
|
|
2016
|
|
8 |
p. 670-673
4 p.
|
artikel
|
| 82 |
Readmissions and Diuretic Dosing
|
Peled, Harry
|
|
2017
|
|
8 |
p. 618-
1 p.
|
artikel
|
| 83 |
Redefining “Winning” and Its Implications in Heart Failure Clinical Trials ∗
|
Carson, Peter E.
|
|
2017
|
|
8 |
p. 600-602
3 p.
|
artikel
|
| 84 |
Re-Examination of the BEST Trial Using Composite Outcomes, Including Emergency Department Visits
|
Shen, Li
|
|
2017
|
|
8 |
p. 591-599
9 p.
|
artikel
|
| 85 |
Refining Endpoint Measures in Clinical Trials for Hypertrophic Cardiomyopathy
|
Rowin, Ethan J.
|
|
|
|
8 |
p. 540-542
|
artikel
|
| 86 |
Regional Adipose Distribution and its Relationship to Exercise Intolerance in Older Obese Patients Who Have Heart Failure With Preserved Ejection Fraction
|
Haykowsky, Mark J.
|
|
2018
|
|
8 |
p. 640-649
|
artikel
|
| 87 |
Reply
|
Stiermaier, Thomas
|
|
|
|
8 |
p. 602
|
artikel
|
| 88 |
Reply
|
Park, Jin Joo
|
|
2018
|
|
8 |
p. 723
|
artikel
|
| 89 |
Reply
|
Woronow, Daniel
|
|
2018
|
|
8 |
p. 721-722
|
artikel
|
| 90 |
Reply
|
Sud, Maneesh
|
|
2017
|
|
8 |
p. 618-619
2 p.
|
artikel
|
| 91 |
Reply
|
Beadle, Roger M.
|
|
2015
|
|
8 |
p. 660-
1 p.
|
artikel
|
| 92 |
Reply
|
DeFilippis, Ersilia M.
|
|
2019
|
|
8 |
p. 732
|
artikel
|
| 93 |
Reply
|
Keshvani, Neil
|
|
|
|
8 |
p. 611
|
artikel
|
| 94 |
Reply
|
Keshvani, Neil
|
|
|
|
8 |
p. 609-610
|
artikel
|
| 95 |
Reply
|
Greene, Stephen J.
|
|
|
|
8 |
p. 606-608
|
artikel
|
| 96 |
Reply
|
Cunningham, Jonathan W.
|
|
|
|
8 |
p. 698-699
|
artikel
|
| 97 |
Reply
|
Witteles, Ronald M.
|
|
|
|
8 |
p. 696-697
|
artikel
|
| 98 |
Right Ventricular Contractile Reserve and Pulmonary Circulation Uncoupling During Exercise Challenge in Heart Failure
|
Guazzi, Marco
|
|
2016
|
|
8 |
p. 625-635
11 p.
|
artikel
|
| 99 |
Risk for Heart Failure
|
Uijl, Alicia
|
|
2019
|
|
8 |
p. 637-647
|
artikel
|
| 100 |
Risk Models for Prediction of Implantable Cardioverter-Defibrillator Benefit
|
Kristensen, Søren Lund
|
|
2019
|
|
8 |
p. 717-724
|
artikel
|
| 101 |
Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice
|
Witteles, Ronald M.
|
|
2019
|
|
8 |
p. 709-716
|
artikel
|
| 102 |
Seven Metrics That Will Determine Your Cardiovascular Success or Failure ∗
|
Ballantyne, Christie M.
|
|
2019
|
|
8 |
p. 648-650
|
artikel
|
| 103 |
Sex Differences in Outcomes of LVAD Patients Bridged to Transplant
|
Wehbe, Ramsey M.
|
|
2019
|
|
8 |
p. 731
|
artikel
|
| 104 |
Should Men Also Fear Strong Positive Emotions?
|
Nadir, Maha
|
|
|
|
8 |
p. 601
|
artikel
|
| 105 |
Should We Be for ASCT?
|
Trachtenberg, Barry H.
|
|
|
|
8 |
p. 695-696
|
artikel
|
| 106 |
Skeletal Muscle Mitochondrial Content, Oxidative Capacity, and Mfn2 Expression Are Reduced in Older Patients With Heart Failure and Preserved Ejection Fraction and Are Related to Exercise Intolerance
|
Molina, Anthony J.A.
|
|
2016
|
|
8 |
p. 636-645
10 p.
|
artikel
|
| 107 |
Sodium-Glucose Co-Transporter-2 Inhibitors and Cardiac Outcomes Among Patients Treated With Anthracyclines
|
Gongora, Carlos A.
|
|
|
|
8 |
p. 559-567
|
artikel
|
| 108 |
Sodium-Glucose Co-Transporter-2 Inhibitor Therapy During Anthracycline Treatment
|
Khouri, Michel G.
|
|
|
|
8 |
p. 568-570
|
artikel
|
| 109 |
Statins and Exercise Training Response in Heart Failure Patients
|
Kelly, Jacob P.
|
|
2016
|
|
8 |
p. 617-624
8 p.
|
artikel
|
| 110 |
Sudden Death in Heart Failure With Preserved Ejection Fraction
|
Vaduganathan, Muthiah
|
|
2018
|
|
8 |
p. 653-661
|
artikel
|
| 111 |
Supranormal Left Ventricular Ejection Fraction, Stroke Volume, and Cardiovascular Risk
|
Shah, Sonia
|
|
|
|
8 |
p. 583-594
|
artikel
|
| 112 |
Temporal Trends in the Incidence of and Mortality Associated With Heart Failure With Preserved and Reduced Ejection Fraction
|
Tsao, Connie W.
|
|
2018
|
|
8 |
p. 678-685
|
artikel
|
| 113 |
The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF
|
Savji, Nazir
|
|
2018
|
|
8 |
p. 701-709
|
artikel
|
| 114 |
The Broad Spectrum of HIV-Related Cardiovascular Disease ∗
|
Shah, Monica R.
|
|
2015
|
|
8 |
p. 600-602
3 p.
|
artikel
|
| 115 |
The Changing Landscape of Atrial Fibrillation
|
Ko, Darae
|
|
2017
|
|
8 |
p. 561-564
4 p.
|
artikel
|
| 116 |
The Day That Changed My Life—For the Better
|
Whitaker, Kylor
|
|
2019
|
|
8 |
p. 728-729
|
artikel
|
| 117 |
The Globalization of Heart Failure Research
|
O’Connor, Christopher M.
|
|
2015
|
|
8 |
p. 657-658
2 p.
|
artikel
|
| 118 |
The Heart Failure Collaboratory Medical Therapy Score
|
Hong, Kimberly N.
|
|
|
|
8 |
p. 556-558
|
artikel
|
| 119 |
The Ongoing Evolution of Optimal Clinical Endpoints for Heart Failure Trials ∗
|
Krum, Henry
|
|
2015
|
|
8 |
p. 615-617
3 p.
|
artikel
|
| 120 |
The PARAGON-HF Trial
|
Gronda, Edoardo
|
|
|
|
8 |
p. 697-698
|
artikel
|
| 121 |
The Transition From Hypertension to Heart Failure
|
Messerli, Franz H.
|
|
2017
|
|
8 |
p. 543-551
9 p.
|
artikel
|
| 122 |
The Urgent Need for More Cardiac Rehabilitation in the Aim to “Preserve” Patients With Heart Failure
|
Leggio, Massimo
|
|
|
|
8 |
p. 610
|
artikel
|
| 123 |
Time to Diuretic in Acute Heart Failure
|
Wussler, Desiree
|
|
2018
|
|
8 |
p. 722
|
artikel
|
| 124 |
Treating Obesity in Heart Failure
|
Hall, Michael E.
|
|
2019
|
|
8 |
p. 688-690
|
artikel
|
| 125 |
Trends in the Use of Guideline-Directed Therapies Among Dialysis Patients Hospitalized With Systolic Heart Failure
|
Pandey, Ambarish
|
|
2016
|
|
8 |
p. 649-661
13 p.
|
artikel
|
| 126 |
Tricuspid Regurgitation and Right Heart Failure
|
Batchelor, Wayne
|
|
|
|
8 |
p. 637-639
|
artikel
|
| 127 |
Trying to Make Progress on Survival in a Complicated Area
|
Carson, Peter E.
|
|
2018
|
|
8 |
p. 662-664
|
artikel
|
| 128 |
Validation of the Kansas City Cardiomyopathy Questionnaire in Symptomatic Obstructive Hypertrophic Cardiomyopathy
|
Nassif, Michael
|
|
|
|
8 |
p. 531-539
|
artikel
|
| 129 |
Weighty Matters in HFpEF and Aging ∗
|
Forman, Daniel E.
|
|
2018
|
|
8 |
p. 650-652
|
artikel
|
| 130 |
What Do Cardiology and Homeopathy Have in Common?
|
Cleland, John G.F.
|
|
2017
|
|
8 |
p. 611-614
4 p.
|
artikel
|
| 131 |
Why Should We Publish All Clinical Trials?
|
O’Connor, Christopher M.
|
|
2019
|
|
8 |
p. 730
|
artikel
|
Tijdschrift beschrijving